Tiger's take - At a high level strategically, RTI Surgical's acquisition of Collagen Solutions strengthens its position in the regenerative medicine market by expanding its soft tissue portfolio with advanced collagen-based biomaterials. This move enhances RTI’s access to high-growth clinical areas such as cardiac, sports medicine, and orthopedics, while accelerating innovation and development of new products for OEM customers. The acquisition supports RTI's goal of providing innovative, patient-centered solutions and aligns with its growth strategy, backed by its main shareholder, Montagu.
RTI Surgical Announces Agreement to Acquire Collagen Solutions (press release)
websites - https://www.collagensolutions.com/ & www.rtisurgical.com
Further expands RTI’s soft tissue portfolio of xenograft and allograft materials at scale
Improves access to high-growth cardiac, sports medicine and orthopedic clinical markets
Enables accelerated development of innovative biomaterials for existing and new OEM customers
RTI Surgical (“RTI” or “the Company”), a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine, announced toda...
